Amarin Corp Plc (AMRN)

[jessellivermore]

FF..

"A large part of me wonders if Vascepa will ever be approved as a triglyceride lowering agent, no matter how good the R-IT results are"

R-I is an outcomes study. The question it addresses is will Vascepa as an add on drug to patients at risk for CVD, on adequate statins, further lowered CVD risk.

The mechanism of action is not germane as long as it does not enter safety issues into the trial...The trig question is only of academic interest. So sleep peacefully.

":>) JL